- CASI Pharmaceuticals, Inc (DE)

Dashboard

Manage Tickers Link Financial Account

CASICASI Pharmaceuticals, Inc (DE)

Nasdaq casipharmaceuticals.com

$ 5.59 $ 0.09 (1.64 %)

Monday, 01-Jul-2024 14:09:43 EDT

CLICK TO SEE RELEVANT LITIGATION UPDATES

Y-mAbs Therapeutics, Inc. | YMAB | Take Action!

QQQ $ 481.04 $ 0.74 (0.16 %)

DIA $ 391.72 $ 0.59 (0.15 %)

SPY $ 544.81 $ -0.60 (-0.11 %)

TLT $ 89.92 $ -0.50 (-0.55 %)

GLD $ 215.29 $ 0.28 (0.13 %)

Previous Close

$ 5.5

Open

$ 5.45

Bid

$ 5.52 x 100

Ask

$ 0.00 x 0

Day's Range

$ 5.33 - $ 5.60

52 Week Range

$ 1.90 - $ 8.48

Volume

810,683

Average Volume

na

Market Cap

75.06M

Beta (5Y Monthly)

$ 0.43

PE Ratio (TTM)

nm

EPS (TTM)

TBD

Earnings Date

na

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

na

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
1	11-14-2022	09-30-2022	10-Q
2	08-12-2022	06-30-2022	10-Q
3	05-12-2022	03-31-2022	10-Q
4	03-28-2022	12-31-2021	10-K
5	11-12-2021	09-30-2021	10-Q
6	08-12-2021	06-30-2021	10-Q
7	05-13-2021	03-31-2021	10-Q
8	03-30-2021	12-31-2020	10-K
9	11-09-2020	09-30-2020	10-Q
10	08-10-2020	06-30-2020	10-Q
11	05-11-2020	03-31-2020	10-Q
12	03-16-2020	12-31-2019	10-K
13	11-12-2019	09-30-2019	10-Q
14	08-09-2019	06-30-2019	10-Q
15	05-15-2019	03-31-2019	10-Q
16	03-29-2019	12-31-2018	10-K
17	11-14-2018	09-30-2018	10-Q
18	08-14-2018	06-30-2018	10-Q
19	05-15-2018	03-31-2018	10-Q
20	03-29-2018	12-31-2017	10-K
21	11-14-2017	09-30-2017	10-Q
22	08-14-2017	06-30-2017	10-Q
23	05-15-2017	03-31-2017	10-Q
24	03-31-2017	12-31-2016	10-K
25	11-14-2016	09-30-2016	10-Q
26	08-15-2016	06-30-2016	10-Q
27	05-13-2016	03-31-2016	10-Q
28	03-28-2016	12-31-2015	10-K
29	11-13-2015	09-30-2015	10-Q
30	08-14-2015	06-30-2015	10-Q
31	05-15-2015	03-31-2015	10-Q
32	03-27-2015	12-31-2014	10-K
33	11-14-2014	09-30-2014	10-Q
34	08-14-2014	06-30-2014	10-Q
35	05-15-2014	03-31-2014	10-Q
36	03-21-2014	12-31-2013	10-K
37	11-14-2013	09-30-2013	10-Q
38	08-14-2013	06-30-2013	10-Q
39	05-15-2013	03-31-2013	10-Q
40	03-21-2013	12-31-2012	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Core News & Articles

Market-Moving News for June 27th
06/27/2024 12:37:40

CASI: 92% | CASI Pharmaceuticals Announced Plan To Submit CID-103 IND Application; Also Announces Receipt Of A Non-binding Prop...

CASI Pharmaceuticals Announced Plan To Sub...
06/26/2024 20:16:48

CASI Pharmaceuticals Announces A $15M Priv...
06/26/2024 20:12:57

12-health-care-stocks-moving-in-fridays-pre-market-session

12 Health Care Stocks Moving In Friday's P...
06/21/2024 12:08:00

12-health-care-stocks-moving-in-thursdays-intraday-session

12 Health Care Stocks Moving In Thursday's...
06/20/2024 16:32:10

HC Wainwright & Co. Maintains Buy on CASI ...
05/15/2024 15:46:43

HC Wainwright & Co. analyst Sean Lee maintains CASI Pharmaceuticals (NASDAQ:CASI) with a Buy and lowers the price target...

12-health-care-stocks-moving-in-wednesdays-pre-market-session

12 Health Care Stocks Moving In Wednesday'...
05/15/2024 12:06:56

CASI Pharmaceuticals Gets FDA Clearance On...
05/15/2024 12:04:58

CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a biopharmaceutical company specializing in the development and commercialization of ...

CASI Pharmaceuticals Q1 EPS $(0.71) Misses...
05/14/2024 12:23:53

CASI Pharmaceuticals (NASDAQ:CASI) reported quarterly losses of $(0.71) per share which missed the analyst consensus estimate o...

CASI Pharmaceuticals Discloses Material De...
04/08/2024 21:03:35

On April 8, 2024, CASI Pharmaceuticals, announced that, with respect to the Company’s previously announced dispute with Juventa...

CASI Pharmaceuticals Wins Emergency Relief...
04/08/2024 11:34:32

On April 8, 2024, CASI Pharmaceuticals, Inc., a Cayman Islands incorporated company (“CASI” or the “Company”) announced that, ...

CASI Pharmaceuticals Q4 EPS $(0.45) Misses...
03/28/2024 12:45:21

CASI Pharmaceuticals (NASDAQ:CASI) reported quarterly losses of $(0.45) per share which missed the analyst consensus estimate o...

recap-casi-pharmaceuticals-q4-earnings

Recap: CASI Pharmaceuticals Q4 Earnings
03/28/2024 12:20:12

CASI Pharmaceuticals FY2023 GAAP EPS $(2.0...
03/28/2024 11:29:55

CASI Pharmaceuticals (NASDAQ:CASI) reported quarterly losses of $(2.02) per share which missed the analyst consensus estimate o...

12-health-care-stocks-moving-in-fridays-intraday-session

12 Health Care Stocks Moving In Friday's I...
03/08/2024 17:31:06

12-health-care-stocks-moving-in-thursdays-pre-market-session

12 Health Care Stocks Moving In Thursday's...
03/07/2024 13:06:06

casi-pharmaceuticals-blood-cancer-drug-shows-encouraging-clinical-efficacy-in-chinese-patients

CASI Pharmaceuticals Blood Cancer Drug Sho...
03/05/2024 17:16:54

CASI Pharmaceuticals and BioInvent share promising results for BI-1206 in treating relapsed/refractory indolent Non-Hodgkin'...

CASI Pharmaceuticals Shares Halted On Circ...
03/05/2024 14:41:21

12-health-care-stocks-moving-in-tuesdays-pre-market-session

12 Health Care Stocks Moving In Tuesday's ...
03/05/2024 13:09:49

$casi-pharmaceuticals-report-interim-phase-1-data-for-bi-1206-in-the-treatment-of-relapsedrefractory-indolent-non-hodgkins-lymphoma-in-china$

CASI Pharmaceuticals Report Interim Phase ...
03/05/2024 12:04:08

CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a biopharmaceutical company specializing in the development and commercialization of ...

CLASS ACTION DEADLINES - JOIN NOW!

07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)

07/01/2024 Equinix, Inc. (EQIX)

07/02/2024 Intel Corporation (INTC)

07/05/2024 AXT, Inc. (AXTI)

07/05/2024 Altimmune, Inc. (ALT)

07/09/2024 Li Auto Inc. (LI)

07/12/2024 Inari Medical, Inc. (NARI)

07/12/2024 Sprout Social, Inc. (SPT)

07/15/2024 UnitedHealth Group Inc. (UNH)

07/16/2024 Teladoc Health, Inc. (TDOC)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)